We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+38.45%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$617M
AUM Growth
+$270M
Cap. Flow
+$81.4M
Cap. Flow %
13.2%
Top 10 Hldgs %
38.27%
Holding
109
New
46
Increased
22
Reduced
16
Closed
21

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$15.9M
2
ABT icon
Abbott
ABT
+$12.9M
3
DBVT
DBV Technologies
DBVT
+$8.68M
4
CELG
Celgene Corp
CELG
+$8.12M
5
CYNO
Cynosure, Inc. Class A
CYNO
+$7.79M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$12.1M
2
MDT icon
Medtronic
MDT
+$8.68M
3
BLUE
bluebird bio
BLUE
+$6.15M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$5.68M
5
CNMD icon
CONMED
CNMD
+$5.52M

Sector Composition

Rank Sector Weight
1 Healthcare 55.34%
2 Miscellaneous 44.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
101
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-215,000
Closed -$12.1M
CLVS
102
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-500,000
Closed -$6.86M
RDUS
103
DELISTED
Radius Health, Inc.
RDUS
– –
-20,000
Closed -$735K
GWPH
104
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-130,000
Closed -$11.9M
IMMU
105
CALL
DELISTED
Immunomedics Inc
IMMU
– –
-200,000
Closed -$464K
TSRO
106
CALL
DELISTED
TESARO, Inc.
TSRO
– –
-50,000
Closed -$4.2M
OCRX
107
DELISTED
Ocera Therapeutics, Inc.
OCRX
– –
-35,801
Closed -$68K
RPTP
108
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
– –
-600,000
Closed -$3.22M
MDVN
109
DELISTED
MEDIVATION, INC.
MDVN
– –
-10,500
Closed -$633K
1 2 3 4
5

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Ghost Tree Capital held 109 positions worth $617M, up 78% from $346M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ghost Tree Capital deployed $81.4M of net new capital in Q3 2016, opening 46 new positions and adding to 22 existing holdings. Its largest new stake was Zimmer Biomet: 128,750 shares worth $16.3M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 60% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was bluebird bio, an estimated $6.15M trimmed.

  • Ghost Tree Capital's largest Q3 2016 buy was Zimmer Biomet: 128,750 shares worth $16.3M.
  • Ghost Tree Capital added most to Celgene Corp in Q3 2016, an estimated $8.12M increase.
  • Ghost Tree Capital's biggest Q3 2016 reduction was bluebird bio, cutting an estimated $6.15M.
  • Ghost Tree Capital fully exited IVERIC bio, Inc. Common Stock in Q3 2016, selling an estimated $12.1M.
  • Ghost Tree Capital's ten largest holdings make up 38% of its $617M portfolio in Q3 2016.
  • Ghost Tree Capital opened 46 new positions and closed 21 in Q3 2016.
  • Ghost Tree Capital's portfolio value rose 78% quarter-over-quarter to $617M.

Based on Ghost Tree Capital's 13F filing for Q3 2016, filed 14 Nov 2016.